Skip to content
  • Careers
  • Contact Us
Actuate Therapeutics
  • About Us
  • Our Science
  • Pipeline
  • Clinical Trials
  • Publications
  • Investors
    • Overview
    • News
    • Events
    • SEC Filings
    • Corporate Governance
    • Stock Information
    • FAQs
Actuate Therapeutics
  • About Us
  • Timeline
  • Our Science
  • Pipeline
  • Clinical Trials
  • Publications
  • Investors
    • Overview
    • News
    • Events
    • SEC Filings
    • Corporate Governance
    • Stock Information
    • FAQs
  • Careers
  • Contact Us

News

NEWS

Found 46 Items
June 20, 2025
Actuate Therapeutics Reports Positive Biomarker and Machine Learning Data from Phase 2 Elraglusib Trial in First-Line Treatment of Metastatic Pancreatic Cancer at ASCO
June 16, 2025
Actuate Therapeutics Announces Inclusion in the Russell 3000® and Russell 2000® Indexes
June 2, 2025
Actuate Therapeutics Shares Highlights from KOL Event on Positive Topline Elraglusib Phase 2 Data in First-Line Treatment of Metastatic Pancreatic Cancer
May 31, 2025
Actuate Therapeutics Presents Topline Elraglusib Phase 2 Data at ASCO 2025 Annual Meeting: Trial Meets Primary Endpoint of Median Overall Survival and Doubles 1-Year Survival in First-Line Treatment of Metastatic Pancreatic Cancer
May 22, 2025
Actuate Therapeutics Announces Details for 2025 ASCO Annual Meeting Presentation on Topline Elraglusib Phase 2 Data in First-Line Treatment of Metastatic Pancreatic Cancer
May 7, 2025
Actuate Therapeutics to Host KOL Event on Topline Phase 2 Data of Elraglusib in Metastatic Pancreatic Ductal Adenocarcinoma During ASCO Annual Meeting

12345...»

Email Alerts Sign-Up

Investor Relations Contact

Mike Moyer
LifeSci Advisors
617-308-4306
mmoyer@lifesciadvisors.com

Media Contacts

Ignacio Guerrero-Ros, Ph.D., or David Schull
Russo Partners, LLC
(858) 717-2310 or (646) 942-5604
Ignacio.guerrero-ros@russopartnersllc.com
David.schull@russopartnersllc.com

Actuate Therapeutics

Contact Us:
info@actuatetherapeutics.com

  • LinkedIn
  • Twitter

About Us

  • Overview
  • Leadership
  • Board of Directors
  • Timeline
  • Careers
  • Contact Us

Our Science

  • The Target
  • Elra
  • Pipeline
  • Publications

Clinical Trials

  • Pancreatic Cancer
  • Ewing sarcoma

Investors

  • Overview
  • News
  • Events
  • SEC Filings
  • Corporate Governance
  • Stock Information
  • FAQs

Copyright © 2025 Actuate Therapeutics, Inc.

Manage Cookie Consent
  • Expanded Access Policy
  • Privacy Notice
  • Accessibility
  • Cookie Policy
X
This website uses cookies to improve your experience. By clicking “Accept”, you consent to the use of ALL the cookies. For more information, see our Cookies Policy.
Cookie settingsREJECTACCEPT ALL
Manage Cookie Consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Functional
Always Enabled
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
CookieDurationDescription
GetLocalTimeZonesessionNo description
PHPSESSIDsessionThis cookie is native to PHP applications. The cookie is used to store and identify a users' unique session ID for the purpose of managing user session on the website. The cookie is a session cookies and is deleted when all the browser windows are closed.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
elementorneverThis cookie is used by the website's WordPress theme. It allows the website owner to implement or change the website's content in real-time.
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
CookieDurationDescription
_ga2 yearsThe _ga cookie, installed by Google Analytics, calculates visitor, session and campaign data and also keeps track of site usage for the site's analytics report. The cookie stores information anonymously and assigns a randomly generated number to recognize unique visitors.
_ga_7GWH3VTDXR2 yearsThis cookie is installed by Google Analytics.
Save & Accept